Operating Expenses 更改
AbbVie USD 9.71B 96M 2025-06
Acadia Pharmaceuticals USD 232.19M 7.16M 2025-06
ALKERMES USD 297.68M 4.96M 2025-06
Amgen USD 6.52B 337M 2025-06
Bayer EUR 10.73B 688M 2025-06
Biogen USD 1.79B 326.1M 2025-06
BioMarin Pharmaceutical USD 548.52M 27.27M 2025-06
Bristol-Myers Squibb USD 8.5B 265M 2025-06
Eli Lilly USD 8.54B 1.22B 2025-06
Gilead Sciences USD 4.35B 80M 2025-06
Incyte USD 904.7M 56.97M 2025-06
Merck USD 9.44B 217M 2025-06
Moderna USD 1.04B 113M 2025-06
Neurocrine Biosciences USD 541.9M 7M 2025-06
Novartis USD 9.97B 1.02B 2025-06
Pfizer USD 11.62B 1.58B 2025-06
PTC Therapeutics USD 213.73M 7.86M 2025-06
Regeneron Pharmaceuticals USD 2.6B 159.1M 2025-06
Sanofi EUR 9.02B 702M 2025-06
Sanofi EUR 6.77B 3.75B 2024-12
Sarepta Therapeutics USD 495.51M 549.73M 2025-06
Teva Pharmaceutical Industries USD 3.28B 95M 2025-06
Ultragenyx Pharmaceutical USD 274.38M 7.85M 2025-06
United Therapeutics USD 521.7M 110.1M 2025-06
Vertex Pharmaceuticals USD 1.81B 71.4M 2025-06


Biogen 营业费用 - 当前值,历史数据,预测,统计,图表和经济日历 - Aug 2025.